View Item 

Show simple item record

Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome

dc.contributor.authorRubenstein, Joel H.en_US
dc.contributor.authorNojkov, B.en_US
dc.contributor.authorKorsnes, Sherylen_US
dc.contributor.authorAdlis, Susan A.en_US
dc.contributor.authorShaw, M. J.en_US
dc.contributor.authorWeinman, B.en_US
dc.contributor.authorInadomi, John M.en_US
dc.contributor.authorSaad, Richard J.en_US
dc.contributor.authorChey, William D.en_US
dc.date.accessioned2010-06-01T18:16:25Z
dc.date.available2010-06-01T18:16:25Z
dc.date.issued2007-08en_US
dc.identifier.citationRUBENSTEIN, J. H.; NOJKOV, B.; KORSNES, S.; ADLIS, S. A.; SHAW, M. J.; WEINMAN, B.; INADOMI, J. M.; SAAD, R.; CHEY, W. D. (2007). "Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome." Alimentary Pharmacology & Therapeutics 26(3): 443-452. <http://hdl.handle.net/2027.42/71484>en_US
dc.identifier.issn0269-2813en_US
dc.identifier.issn1365-2036en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71484
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17635379&dopt=citationen_US
dc.format.extent649965 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2007 The Authors Journal compilation 2007 Blackwell Publishing Ltden_US
dc.titleOesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndromeen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOtolaryngologyen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum* Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI, USAen_US
dc.contributor.affiliationother† Health Research Center, Institute for Research and Education, Park Nicollet Clinic, Health System Minnesota, MN, USAen_US
dc.contributor.affiliationother† Gastroenterology Division, University of California, San Francisco, CA, USAen_US
dc.identifier.pmid17635379en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71484/1/j.1365-2036.2007.03393.x.pdf
dc.identifier.doi10.1111/j.1365-2036.2007.03393.xen_US
dc.identifier.sourceAlimentary Pharmacology & Therapeuticsen_US
dc.identifier.citedreferenceDent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 710 – 7.en_US
dc.identifier.citedreferenceZerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006; 101: 1956 – 63.en_US
dc.identifier.citedreferenceFass R. Focussed clinical review: nonerosive reflux disease. Medscape Gastroenterology. 2001; 3: http://www.medscape.com/viewarticle/407966, posted 26 February 2001.en_US
dc.identifier.citedreferenceWatson RGP, Tham TCK, Johnston BT, McDougall NI. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux - the “sensitive oesophagus”. Gut 1997; 40: 587 – 90.en_US
dc.identifier.citedreferenceLind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997; 32: 974 – 9.en_US
dc.identifier.citedreferenceRichter J, Peura D, Benjamin S, Joelsson B, Whipple J. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis. Arch Intern Med 2000; 160: 1810 – 6.en_US
dc.identifier.citedreferenceClouse RE, Richter JE, Heading RC, Janssens J, Wilson JA. Functional esophageal disorders. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II: The Functional Gastrointestinal Disorders, 2nd edn. Lawrence, KS: Allen Press, 2000: 247 – 98.en_US
dc.identifier.citedreferenceRodriguez-Stanley S, Robinson M, Earnest DL, Greenwood-Van Meerveld B, Miner PB, Jr. Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol 1999; 94: 628 – 31.en_US
dc.identifier.citedreferenceTrimble KC, Pryde A, Heading RC. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 1995; 37: 7 – 12.en_US
dc.identifier.citedreferenceRichter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986; 91: 845 – 52.en_US
dc.identifier.citedreferenceHoward PJ, Maher L, Pryde A, Heading RC. Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease. Gut 1991; 32: 128 – 32.en_US
dc.identifier.citedreferenceGracely RH, McGrath P, Dubner R. Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptiors: manipulation of affect by diazepam. Pain 1978a; 5: 19 – 29.en_US
dc.identifier.citedreferenceGracely RH, McGrath P, Dubner R. Ratio scales of sensory and affective verbal pain descriptors. Pain 1978b; 5: 5 – 18.en_US
dc.identifier.citedreferenceLadabaum U, Minoshima S, Owyang C. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications V. Central nervous system processing of somatic and visceral sensory signals. Am J Physiol Gastrointest Liver Physiol 2000; 279: G1 – 6.en_US
dc.identifier.citedreferenceShaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey M. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther 1998; 12: 1067 – 78.en_US
dc.identifier.citedreferenceShaw MJ, Beebe TJ, Adlis SA, Talley NJ. Reliability and validity of the digestive health status instrument in samples of community, primary care, and gastroenterology patients. Aliment Pharmacol Ther 2001; 15: 981 – 7.en_US
dc.identifier.citedreferenceDerogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13: 595 – 605.en_US
dc.identifier.citedreferenceGandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1171 – 8.en_US
dc.identifier.citedreferenceFass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998; 115: 1363 – 73.en_US
dc.identifier.citedreferenceSilverman DHS, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 1997; 112: 64 – 72.en_US
dc.identifier.citedreferenceAvidan B, Sonnenberg A, Giblovich H, Sontag SJ. Reflux symptoms are associated with psychiatric disease. Aliment Pharmacol Ther 2001; 15: 1907 – 12.en_US
dc.identifier.citedreferenceMertz H, Morgan V, Tanner G, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000; 118: 842 – 8.en_US
dc.identifier.citedreferenceWhitehead WE, Palsson OS. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology 1998; 115: 1263 – 71.en_US
dc.identifier.citedreferenceNorth CS, Downs D, Clouse RE, et al. The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol 2004; 2: 787 – 95.en_US
dc.identifier.citedreferenceMiller AR, North CS, Clouse RE, Wetzel RD, Spitznagel EL, Alpers DH. The association of irritable bowel syndrome and somatization disorder. Ann Clin Psychiatry 2001; 13: 25 – 30.en_US
dc.identifier.citedreferenceHalder SL, Locke GR 3rd, Talley NJ, et al. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther 2004; 19: 233 – 42.en_US
dc.identifier.citedreferenceTrimble KC, Farouk R, Pryde A, Douglas S, Heading RC. Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci 1995; 40: 1607 – 13.en_US
dc.identifier.citedreferenceShapiro M, Green C, Bautista JM, et al. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid. Am J Gastroenterol 2006; 101: 1084 – 91.en_US
dc.identifier.citedreferenceBhalla V, Liu J, Puckett JL, Mittal RK. Symptom hypersensitivity to acid infusion is associated with hypersensitivity of esophageal contractility. Am J Physiol Gastrointest Liver Physiol 2004; 287: G65 – 71.en_US
dc.identifier.citedreferenceRao SS, Gregersen H, Hayek B, Summers RW, Christensen J. Unexplained chest pain: the hypersensitive, hyperreactive, and poorly compliant esophagus. Ann Intern Med 1996; 124: 950 – 8.en_US
dc.identifier.citedreferenceVela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001; 120: 1599 – 606.en_US
dc.identifier.citedreferencePeghini PL, Katz PO, Castell DO. Imipramine decreases oesophageal pain perception in human male volunteers. Gut 1998; 42: 807 – 13.en_US
dc.identifier.citedreferencePrakash C, Clouse RE. Long-term outcome from tricyclic antidepressant treatment of functional chest pain. Dig Dis Sci 1999; 44: 2373 – 9.en_US
dc.identifier.citedreferenceVaria I, Logue E, O’Connor C, et al. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J 2000; 140: 367 – 72.en_US
dc.identifier.citedreferenceChey WD, Nojkov B, Saad R, Rai J, Adlis SA, Shaw MJ. Does the absence of erosive esophagitis really predict a worse response to Proton Pump Inhibitor (PPI) therapy in patients with Gastroesophageal Reflux Disease? Gastroenterology 2006; 130 ( Suppl. 2 ): A-179 [Abstract].en_US
dc.identifier.citedreferenceBernstein LM, Baker LA. A clinical test for esophagitis. Gastroenterology 1958; 34: 760 – 81.en_US
dc.identifier.citedreferenceSarkar S, Thompson DG, Woolf CJ, Hobson AR, Millane T, Aziz Q. Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression. Am J Gastroenterol 2004; 99: 1998 – 2006.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2036.2007.03393.x.pdf
Size:
634.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.